lse:azn

American Society of Clinical Oncology annual meeting [Market Discussions] (1)
Well worth reading [Market Discussions] (1)
AstraZeneca successful in late-state lung cancer study [Market Discussions] (1)
Selling signal? [Market Discussions] (3)
New application in Japan [Market Discussions] (1)
New FDA approval [Market Discussions] (1)
EU positive on Tagrisso [Market Discussions] (1)
FDA gives Tagrisso 1st line status [Market Discussions] (1)
A good article to read. Follow the link. [Market Discussions] (1)
Astra Zeneca reassures investors [Market Discussions] (1)
'The FDA has granted the moxetumomab pasudotox BLA Priority Review status [Market Discussions] (1)
Woody's bottled it! [Market Discussions] (1)
FDA Priority Review for AZN new drug [Market Discussions] (1)
Diagnostic tool to help identify which patients to treat. [Market Discussions] (1)
The EU approves AstraZeneca's (AZN +0.2%) Lokelma (sodium zirconium cyclosilicate), [Market Discussions] (1)
AstraZeneca's Farxiga [Market Discussions] (1)
Oh if only... [Market Discussions] (2)
Mystic Trial Results In Second Half of 2018 [Market Discussions] (1)
EMA accepts AstraZeneca's marketing application for dapagliflozin in T1D [Market Discussions] (1)
AstraZeneca's Imfinzi secures FDA approval [Market Discussions] (2)
+91p today, I wonder why [Market Discussions] (6)
More re eek [Market Discussions] (1)
eek [Market Discussions] (2)
Citi on FY results [Market Discussions] (2)
Syndax pharma tie-up [Market Discussions] (4)
Just Bought in [Market Discussions] (2)
AstraZeneca lung cancer drug granted priority review in US [Market Discussions] (1)
AZ submits Tagrisso application in Japan [Market Discussions] (1)
NEW ARTICLE: How I am preparing for a stockmarket correction [Market Discussions] (1)
NEW ARTICLE: Have Neil Woodford and these three other star managers lost their Midas touch? [Market Discussions] (1)